These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 12629333

  • 1. High dose chemotherapy and stem cell support in the treatment of germ cell cancer.
    Margolin K.
    J Urol; 2003 Apr; 169(4):1229-33. PubMed ID: 12629333
    [Abstract] [Full Text] [Related]

  • 2. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
    Pico JL, Fadel E, Ibrahim A, Bourhis JH, Droz JP.
    Bull Cancer; 1995 Apr; 82 Suppl 1():56s-60s. PubMed ID: 7542945
    [Abstract] [Full Text] [Related]

  • 3. Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
    Margolin KA, Doroshow JH, Frankel P, Chow W, Leong LA, Lim D, McNamara M, Morgan RJ, Shibata S, Somlo G, Twardowski P, Yen Y, Kogut N, Schriber J, Alvarnas J, Stalter S.
    Biol Blood Marrow Transplant; 2005 Nov; 11(11):903-11. PubMed ID: 16275593
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group.
    J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors.
    Lorch A, Rick O, Wündisch T, Hartmann JT, Bokemeyer C, Beyer J.
    J Urol; 2010 Jul 15; 184(1):168-73. PubMed ID: 20483152
    [Abstract] [Full Text] [Related]

  • 10. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C, Beyer J, Bokemeyer C, Hartmann JT, Rick O.
    Eur J Cancer; 2008 Jan 15; 44(2):237-43. PubMed ID: 18055194
    [Abstract] [Full Text] [Related]

  • 11. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
    Banna GL, De Giorgi U, Ferrari B, Castagna L, Alloisio M, Marangolo M, Rosti G, Santoro A.
    Biol Blood Marrow Transplant; 2006 Oct 15; 12(10):1085-91. PubMed ID: 17084372
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
    Miki T, Mizutani Y, Akaza H, Ozono S, Tsukamoto T, Terachi T, Naito K, Nonomura N, Hara I, Yoshida O, Japan Blood Cell Transplantation Study Group for Testicular Germ Cell Tumor.
    Int J Urol; 2007 Jan 15; 14(1):54-9. PubMed ID: 17199861
    [Abstract] [Full Text] [Related]

  • 14. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR.
    Eur J Haematol; 2007 Feb 15; 78(2):93-101. PubMed ID: 17313557
    [Abstract] [Full Text] [Related]

  • 15. High-dose chemotherapy for male germ cell tumor.
    Hara I, Miyake H, Yamada Y, Takenaka A, Fujisawa M.
    Int J Urol; 2006 Aug 15; 13(8):1037-44. PubMed ID: 16903926
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
    Hara I, Miyake H, Yamada Y, Yamanaka K, Furukawa J, Kumano M, Takenaka A, Fujisawa M.
    Anticancer Drugs; 2006 Oct 15; 17(9):1057-66. PubMed ID: 17001179
    [Abstract] [Full Text] [Related]

  • 20. Intensive chemotherapy with autologous peripheral blood stem cell transplantation during a 10-year period in 64 patients with germ cell tumor.
    Müller AM, Ihorst G, Waller CF, Dölken G, Finke J, Engelhardt M.
    Biol Blood Marrow Transplant; 2006 Mar 15; 12(3):355-65. PubMed ID: 16503505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.